- 英文名称
- Everolimus Ring-Opening Impurity
- 分子式
- C53H83NO14
- 分子量
- 958.22
- 中文别名
- 依维莫司杂质012-99; 依维莫司杂质29; 依维莫司杂质2; 依维莫司开环醛杂质; 依维莫司逆羟醛降解产物; 依维莫司杂质3; 依维莫司杂质C开环依维莫司; (S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-羟基乙氧基)-3-甲氧基环己基)-2,6,8-三甲基-5,9-二氧代壬-7-烯-3-基 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-二甲氧基-3,9,11-三甲基-12-氧代十三烷基-3,5,7-三烯-1-基)-2-羟基-3-甲基四氢-2H-吡喃-2-基)-2-氧代乙酰基)哌啶-2-羧酸酯; Everolimus Impurity 3; Everolimus Retroaldol Degradation Product; Everolimus Open-Ring Impurity; Everolimus Open-Ring Aldehyde Impurity; Everolimus Impurity 012-99; Everolimus Impurity 2; (2R,3S,6R,7E)-1-[(1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl]-2,6,8-trimethyl-5,9-dioxo-7-nonen-3-yl (2S)-1-[{(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl}(oxo)acetyl]-2-piperidinecarboxylate; [(E,2R,3S,6R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl] (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trienyl]-2-hydroxy-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-carboxylate
- 用途
-
